Breasted JH, editor. The Edwin Smith Surgical Papyrus: published in facsimile and hieroglyphic transliteration with translation and commentary in two volumes, vol. 1. Chicago: University of Chicago Press; 1991.
Clarke CA, Purdie DM, Glaser SL. Population attributable risk of breast cancer in white women associated with immediately modifiable risk factors. BMC Cancer. 2006;6:170.PubMedCrossRef
Botha JL, Bray F, Sanlika R, Parkin DM. Breast cancer incidence and mortality trends in 16 European countries. Europ J Cancer. 2003;39:1718–29.CrossRef
Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin. 2011;61:69–90.PubMedCrossRef
Nagata C, Mizoue T, Tanaka K, Tsuji I, Wakai K, Inoue M, et al. Tobacco smoking and breast cancer risk: an evaluation based on a systematic review of epidemiological evidence among the Japanese population. Jpn J Clin Oncol. 2006;36:387–94.PubMedCrossRef
Maskarinec G, Pagano I, Chen Z, Nagata C, Gram IT. Ethnic and geographic differences in mammographic density and their association with breast cancer incidence. Breast Cancer Res Treat. 2007;104:47–56.PubMedCrossRef
Althuis MD, Dozier JM, Anderson WF, Devesa SS, Brinton LA. Global trends in breast cancer incidence and mortality 1973–1997. Int J Epidemiol. 2005;34:405–12.PubMedCrossRef
MacMahon B, Cole P, Lin TM, Lowe CR, Mirra AP, Ravnihar B, et al. Age at first birth and breast cancer risk. Bull World Health Organ. 1970;43:209–21.PubMed
Hinkula M, Pukkala E, Kyyrönen P, Kauppila A. Grand multiparity and the risk of breast cancer: population-based study in Finland. Cancer Causes Control. 2001;12:491–500.PubMedCrossRef
Ma H, Henderson KD, Sullivan-Halley J, Duan L, Marshall SF, Ursin G, et al. Pregnancy-related factors and the risk of breast carcinoma in situ and invasive breast cancer among postmenopausal women in the California Teachers Study cohort. Breast Cancer Res. 2010;12:R35.PubMedCrossRef
Phipps AI, Chlebowski RT, Prentice R, McTiernan A, Wactawski-Wende J, Kuller LH, et al. Reproductive history and oral contraceptive use in relation to risk of triple-negative breast cancer. J Natl Cancer Inst. 2011;103:1–8.CrossRef
Toniolo P, Grankvist K, Wulff M, Chen T, Johansson R, Schock H, et al. Human chorionic gonadotropin in pregnancy and maternal risk of breast cancer. Cancer Res. 2010;70:6779–86.PubMedCrossRef
Mustacchi P. Ramazzini and Rigoni-Stern on parity and breast cancer. Clinical impression and statistical corroboration. Arch Intern Med. 1961;108:639–42.PubMed
Kroman N, Mouridsen HT. Prognostic influence of pregnancy before, around, and after diagnosis of breast cancer. Breast. 2003;12:516–21.PubMedCrossRef
Kroman N, Melbye M, Mouridsen HT. Prognostic influence of age at diagnosis in premenopausal breast cancer patients. Scand J Surg. 2002;91:305–8.PubMed
Brinton LA, Sherman ME, Carreon JD, Anderson WF. Recent trends in breast cancer among younger women in the United States. J Natl Cancer Inst. 2008;100:1643–8.PubMedCrossRef
Downs JL, Wise PM. The role of the brain in female reproductive aging. Mol Cell Endocrinol. 2009;299:32–8.PubMedCrossRef
Russo IH, Medado J, Russo J. Endocrine influences on mammary gland structure and development. In: Jones TC, Mohr U, Hunt RD, editors. Integument and mammary gland of laboratory animals. Berlin: Springer Verlag; 1989. p. 252–66.
Chen T, Lundin E, Grankvist K, Zeleniuch-Jacquotte A, Wulff M, Afanasyeva Y, et al. Maternal hormones during early pregnancy: a cross-sectional study. Cancer Causes Control. 2010;21:719–27.PubMedCrossRef
Beatson GT. On the treatment of inoperable cases of carcinoma of the mamma: Suggestions for a new method of treatment with illustrative cases. Lancet. 1896;2:104.CrossRef
Russo J, Russo IH. The role of estrogen in the initiation of breast cancer. Steroid Biochem Mol Biol. 2006;102:89–96.CrossRef
Russo J, Russo IH, editors. Molecular basis of breast cancer: prevention and treatment. Berlin: Springer Verlag; 2004.
Lukanova A, Surcel HM, Lundin E, Kaasila M, Lakso HA, Schock H, et al. Circulating estrogens and progesterone during primiparous. pregnancies and risk of maternal breast cancer. Int J Cancer 2011; March16: 000:000–000.
Albrektsen G, Heuch I, Thoresen S, Kvale G. Clinical stage of breast cancer by parity, age at birth, and time since birth: a progressive effect of pregnancy hormones? Cancer Epidemiol Biomarkers Prev. 2006;15:65–9.PubMedCrossRef
Russo IH, Koszalka M, Gimotty PA, Russo J. Protective effect of chorionic gonadotropin on DMBA-induced mammary carcinogenesis. Br J Cancer. 1990;62:243–7.PubMedCrossRef
Russo IH, Koszalka M, Russo J. Comparative study of the influence of pregnancy and hormonal treatment on mammary carcinogenesis. Br J Cancer. 1991;64:481–4.PubMedCrossRef
Russo J, Russo IH. Susceptibility of the mammary gland to carcinogenesis. II. Pregnancy interruption as a risk factor in tumor incidence. Am J Pathol. 1980;100:497–512.PubMed
Russo J, Tay LK, Ciocca D, Russo IH. Molecular and cellular basis of the mammary gland susceptibility to carcinogenesis. Environ Health Perspect. 1983;49:185–99.PubMedCrossRef
Welsch CW. Host factors affecting the growth of carcinogen-induced rat mammary carcinomas: A review and tribute to Charles Brenton Huggins. Cancer Res. 1985;45:3415–43.PubMed
Russo IH, Russo J. Mammary gland neoplasia in long-term rodent studies. Environ Health Perspect. 1996;104:938–67.PubMedCrossRef
McCormick GM, Moon RC. Effect of nursing and litter size on growth of 7,12-dimethylbenz(a)anthracene (DMBA)-induced rat mammary tumors. Br J Cancer. 1967;21:586–91.PubMedCrossRef
Cabanes A, Wang M, Olivo S, DeAssis S, Gustafsson JA, Khan G, et al. Prepubertal estradiol and genistein exposures up-regulate BRCA1 mRNA and reduce mammary tumorigenesis. Carcinogenesis. 2004;25:741–8.PubMedCrossRef
Blakely CM, Stoddard AJ, Belka GK, Dugan KD, Notarfrancesco KL, Moody SE, et al. Hormone-induced protection against mammary tumorigenesis is conserved in multiple rat strains and identifies a core gene expression signature induced by pregnancy. Cancer Res. 2006;66:6421–31.PubMedCrossRef
Lakshmanaswamy R, Guzman RC, Nandi S. Hormonal prevention of breast cancer: significance of promotional environment. Adv Exp Med Biol. 2008;617:469–75.PubMedCrossRef
Medina D, Smith GH. Chemical carcinogen-induced tumorigenesis in parous, involuted mouse mammary glands. J Natl Cancer Inst. 1999;91:967–69.PubMedCrossRef
Medina D, Kittrell FS. p53 function is required for hormone-mediated protection of mouse mammary tumorigenesis. Cancer Res. 2003;63:6140–3.PubMed
Medina D. Chemical carcinogenesis of rat and mouse mammary glands. Breast Dis. 2007;28:63–8.PubMed
Medina D. Premalignant and malignant mammary lesions induced by MMTV and chemical carcinogens. J Mammary Gland Biol Neoplasia. 2008;13:271–7.PubMedCrossRef
Shen Q, Brown PH. Transgenic mouse models for the prevention of breast cancer. Mutat Res. 2005;576:93–110.PubMed
Rajkumar L, Kittrell FS, Guzman RC, Brown PH, Nandi S, Medina D. Hormone-induced protection of mammary tumorigenesis in genetically engineered mouse models. Breast Cancer Res. 2007;9:R12.PubMedCrossRef
Allred DC, Medina D. The relevance of mouse models to understanding the development and progression of human breast cancer. J Mammary Gland Biol Neoplasia. 2008;13:279–88.PubMedCrossRef
Borowsky AD. Choosing a mouse model: Experimental biology in context—The utility and limitations of mouse models of breast cancer. Cold Spring Harb Perspect Biol 2011.
Medina D, Kittrell FS, Hill J, Shepard A, Thordarson G, Brown P. Tamoxifen inhibition of estrogen receptor-alpha-negative mouse mammary tumorigenesis. Cancer Res. 2005;65:3493–6.PubMed
Rao GN, Piegorsch WW, Haseman JK. Influence of body weight on the incidence of spontaneous tumors in rats and mice of long term studies. Am J Clin Nutr. 1987;45:252–60.PubMed
Tarone RE, Chu KC, Ward JM. Variability in the rates of some common naturally occurring tumors in Fischer 344 rats and (C57BLU6N x C3/HeN) F1 (B6C3F,) mice. J Natl Cancer Inst. 1981;66:1175–81.PubMed
Huggins C, Briziarelli G, Sutton H. Rapid induction of mammary carcinoma in the rat and the influence of hormones on the tumors. J Exp Med. 1959;709:25–42.CrossRef
Huggins C, Grand L, Fukunishi R. Aromatic influences in the yields of mammary cancers following administration of 7,12-dimethylbenzanthracene. Proc Natl Acad Sci USA. 1964;57:737–42.CrossRef
Gullino PM, Pettigrew HM, Grantham FH. N-nitrosomethylurea as mammary gland carcinogen in rats. J Natl Cancer Inst. 1975;54:401–14.PubMed
Thordarson G, Lee AV, McCarty M, Van Horn K, Chu O, Chou YC, et al. Growth and characterization of N-methyl-N-nitrosourea-induced mammary tumors in intact and ovariectomized rats. Carcinogenesis. 2001;22:2039–47.PubMedCrossRef
Russo J, Gusterson BA, Rogers AE, Russo IH, Wellings SR, Van Zwieten MJ. Comparative study of human and rat mammary tumorigenesis. Lab Invest. 1990;62:1–32.
Moral R, Wang R, Russo IH, Lamartiniere CA, Pereira J, Russo J. Effect of prenatal exposure to the endocrine disruptor bisphenol A on mammary gland morphology and gene expression signature. J Endocrinol 2008;196:101–12.
Kawaguchi H, Miyoshi N, Miyamoto Y, Souda M, Umekita Y, Yasuda N, et al. Effects of fetal exposure to diethylstilbestrol on mammary tumorigenesis in rats. Vet Med Sci. 2009;71:1599–608.CrossRef
Umekita Y, Souda M, Hatanaka K, Hamada T, Yoshioka T, Kawaguchi H, et al. Gene expression profile of terminal end buds in rat mammary glands exposed to diethylstilbestrol in neonatal period. Toxicol Lett 2011;205:15–25.
Goodman A, Schorge J, Greene MF. The long-term effects of in utero exposures—the DES story. N Engl J Med. 2011;364:2083–4.PubMedCrossRef
Russo IH, Russo J. Primary prevention of breast cancer by hormone-induced differentiation. Recent Results Cancer Res. 2007;174:111–30.PubMedCrossRef
Russo J, Tait L, Russo IH. Susceptibility of the mammary gland to carcinogenesis: III the cell of origin of rat mammary carcinoma. Am J Path. 1983;113:50–66.PubMed
Russo J, Balogh GA, Chen J, Fernandez SV, Fernbaugh R, Heulings R, et al. The concept of stem cell in the mammary gland and its implication in morphogenesis, cancer and prevention. Front Biosci. 2006;11:151–72.PubMedCrossRef
Bennett DC, Peachey LA, Durbin H, Rudland PS. A possible mammary stem cell line. Cell. 1978;15:283–98.PubMedCrossRef
Bussard KM, Smith GH. The mammary gland microenvironment directs progenitor cell fate in vivo. Int J Cell Biol. 2011;2011:451676.PubMed
Navarro VM, Castellano JM, Fernandez-Fernandez R, Barreiro ML, Roa J, Sanchez-Criado JE, et al. Developmental and hormonally regulated messenger ribonucleic acid expression of KiSS-1 and its putative receptor GPR54 in rat hypothalamus and potent LH releasing activity of KiSS-1 peptide. Endocrinology. 2004;145:4565–74.PubMedCrossRef
Kinoshita M, Tsukamura H, Adachi S, Matsui H, Uenoyama Y, Iwata K, et al. Involvement of central metastin in the regulation of preovulatory luteinizing hormone surge and estrous cyclicity in female rats. Endocrinology. 2005;146:4431–6.PubMedCrossRef
Russo IH, Russo J. Role of hormones in mammary cancer initiation and progression. J Mam Gland Biology Neoplasia. 1998;3:49–61.CrossRef
Russo IH, Frederick J, Russo J. Hormone prevention of mammary carcinogenesis by norethynodrel-mestranol. Breast Cancer Res Treat. 1989;14:43–56.PubMedCrossRef
Vanegas JE, Kocdor M, Pereira JS, Kocdor H, Russo J, Snider K, et al. Preventive effect of hCG on rat mammary carcinogenesis. Proc Am Assoc Cancer Res 2009.
Srivastava P, Russo J, Russo IH. Chorionic gonadotropin inhibits mammary carcinogenesis through activation of programmed cell death. Carcinogenesis. 1997;18:1799–808.PubMedCrossRef
Srivastava P, Russo J, Russo IH. Inhibition of rat mammary tumorigenesis by human chorionic gonadotropin is associated with increased expression of inhibin. Mol Carcinog. 1999;26:10–9.PubMedCrossRef
Russo IH, Russo J. Chorionic gonadotropin: a tumoristatic and preventive agent in breast cancer. In: Teicher BA, editor. Drug resistance in oncology. New York: Dekker; 1993. p. 537–60.
McCormick GM, Moon RC. Effect of pregnancy and lactation on growth of mammary tumours induced by 7,12-dimethylbenzanthracene (DMBA). Br J Cancer. 1965;79:160–6.CrossRef
Dao TL, Sunderland H. Mammary carcinogenesis by 3-methylcholanthrene. I. Hormonal aspects in tumor induction and growth. J Natl Cancer Inst. 1959;23:567–85.PubMed
Grubbs CJ, Hill DL, McDonough KC, Peckham JC. N-Nitroso-N-methylurea-induced mammary carcinogenesis: effect of pregnancy on preneoplastic cells. J Natl Cancer Inst. 1983;71:625–8.PubMed
Jordan VC. Effect of tamoxifen (ICI 46,474) on the initiation and growth of DMBA-induced rat mammary carcinoma. Eur J Cancer. 1976;12:419–24.PubMed
Weroha SJ, Li SA, Tawfik O, Li JJ. Overexpression of cyclins D1 and D3 during estrogen-induced breast oncogenesis in female ACI rats. Carcinogenesis. 2006;27:491–8.PubMedCrossRef
Li SA, Weroha SJ, Tawfik O, Li JJ. Prevention of solely estrogen-induced mammary tumors in female aci rats by tamoxifen: evidence for estrogen receptor mediation. J Endocrinol. 2002;175:297–305.PubMedCrossRef
Russo J, Fernandez SV, Russo PA, Fernbaugh R, Sheriff FS, Lareef HM, et al. 17-Beta-estradiol induces transformation and tumorigenesis in human breast epithelial cells. FASEB J. 2006;20:1622–34.PubMedCrossRef
Russo IH, Gimotty P, Dupuis M, Russo J. Effect of medroxyprogesterone acetate on the response of the rat mammary gland to carcinogenesis. Br J Cancer. 1989;59:210–6.PubMedCrossRef
Lanari C, Lamb CA, Fabris VT, Helguero LA, Soldati R, Bottino MC, et al. The MPA mouse breast cancer model: evidence for a role of progesterone receptors in breast cancer. Endocr Relat Cancer. 2009;16:333–50.PubMedCrossRef
Russo J, Balogh GA, Heulings R, Mailo DA, Moral R, Russo PA, et al. Molecular basis of pregnancy-induced breast cancer protection. Eur J Cancer Prev. 2006;15:306–42.PubMedCrossRef
Wagner KU, Boulanger CA, Henry MD, Sgagias M, Hennighausen L, Smith GH. An adjunct mammary epithelial cell population in parous females: its role in functional adaptation and tissue renewal. Development. 2002;129:1377–86.PubMed
Boulanger CA, Wagner KU, Smith GH. Parity-induced mouse mammary epithelial cells are pluripotent, self-renewing and sensitive to TGF-beta 1 expression. Oncogene. 2005;24:552–60.PubMedCrossRef
Booth BW, Boulanger CA, Smith GH. Selective segregation of DNA strands persists in long-label-retaining mammary cells during pregnancy. Breast Cancer Res. 2008;10:R90.PubMedCrossRef
Blackshaw S, Scholpp S, Placzek M, Ingraham H, Simerly R, Shimogori T. Molecular pathways controlling development of thalamus and hypothalamus: from neural specification to circuit formation. J Neurosci. 2010;30:14925–30.PubMedCrossRef
Hendriks AE, Lavens JS, Valkenburg O, Fong SL, Fauser BC, de Ridder MA, et al. Fertility and ovarian function in high-dose estrogen-treated tall women. J Clin Endocrinol Metab. 2011;96:1098–105.PubMedCrossRef
Russo J, Russo IH. Development of human mammary gland. In: Neville MC, Daniel C, editors. The mammary gland development, regulation and function. New York: Plenum; 1987. p. 67–93.
Russo J, Rivera R, Russo IH. Influence of age and parity on the development of the human breast. Breast Cancer Res Treat. 1992;23:211–8.PubMedCrossRef
Howell A, Evans GD. Hormone replacement therapy and breast cancer. Recent Results Cancer Res. 2011;188:115–24.PubMedCrossRef
Lathi RB, Fisher SJ, Giudice LC. Implantation and placental physiology in early human pregnancy: the role of the maternal decidua and the trophoblast. In: De Groot L, Jameson LJ, editors. Endocrinology. Philadelphia: Elsevier; 2006. p. 3341–51.
Parry S, Strauss III F. Placental hormones. In: De Groot L, Jameson LJ, editors. Endocrinology. Philadelphia: Elsevier; 2006. p. 3353–67.
Alvarado MV, Ho T-Y, Russo J, Russo IH. Human chorionic gonadotropin regulates the synthesis of inhibin in the ovary and the mammary gland of rats. Endocrine. 1994;2:1–10.
Alvarado ME, Alvarado NE, Russo J, Russo IH. Human chorionic gonadotropin inhibits proliferation and induces expression of inhibin in human breast epithelial cells in vitro. In Vitro. 1994;30A:4–8.
Horikoshi Y, Matsumoto H, Takatsu Y, Ohtaki T, Kitada C, Usuki S, et al. Dramatic Elevation of plasma metastin concentrations in human pregnancy: metastin as a novel placenta-derived hormone in humans. J Clin Endocrinol Metab. 2003;88:914–9.PubMedCrossRef
McGregor, Land CE, Choi K, Tokuoka S, Liu PI, Wakabayashi I, et al. Breast cancer incidence among atomic bomb survivors, Hiroshima and Nagaski 1950–1989. J Natl Cancer Inst. 1977;59:799–811.PubMed
Cutuli B, Borel C, Dhermain F, Magrini SM, Wasserman TH, Bogart JA, et al. Breast cancer occurred after treatment for Hodgkin's disease: analysis of 133 cases. Radiother Oncol. 2001;59:247–55.PubMedCrossRef
Johnson KC, Miller AB, Collishaw NE, Palmer JR, Hammond SK, Salmon AG, et al. Active smoking and secondhand smoke increase breast cancer risk: the report of the Canadian expert panel on tobacco smoke and breast cancer risk (2009). Tob Control. 2011;20:e2.PubMedCrossRef
Johansson AL, Andersson TM, Hsieh CC, Cnattingius S, Lambe M. Increased mortality in women with breast cancer detected during pregnancy and different periods postpartum. Cancer Epidemiol Biomarkers Prev. 2011.
Hahn RA, Moolgavkar SH. Nulliparity, decade of first birth, and breast cancer in Connecticut cohorts, 1855 to 1945: an ecological study. Am J Public Health. 1989;79:1503–7.PubMedCrossRef
Mathews TJ, Hamilton BE. Delayed childbearing: more women are having their first child later in life. NCHS data brief, No. 21. Hyattaville: National Center for Health Statistics; 2009.
Balogh GA, Heulings R, Mailo DA, Russo PA, Sheriff F, Russo IH, et al. Genomic signature induced by pregnancy in the human breast. Int J Oncol. 2006;28:399–410.PubMed
Russo J, Balogh GA, Russo IH. Full-term pregnancy induces a specific genomic signature in the human breast. Cancer Epidemiol. Biomarkers Prev. 2008;17:51–66.CrossRef
George K, Kamath MS. Fertility and age. J Hum Reprod Sci. 2010;3:121–3.PubMedCrossRef
Homan GF, Davies M, Norman R. The impact of lifestyles factors on reproductive performance in the general population and those undergoing infertility treatment. Hum Reprod Update. 2007;13:209–23.PubMedCrossRef
Gleicher N, Weghofer A, Barad DH. Defining ovarian reserve to better understand ovarian aging. Reprod Biol Endocrinol. 2011;9:23.PubMedCrossRef
Wise PM, Smith MJ, Dubal DB, Wilson ME, Rau SW, Cashion AB, et al. Neuroendocrine modulation and repercussions of female reproductive aging. Recent Prog Horm Res. 2002;57:235–56.PubMedCrossRef
Danforth DR, Arbogast LK, Mroueh J, Kim MH, Kennard EA, Seifer DB, et al. Dimeric inhibin: a direct marker of ovarian ageing. Fertil Steril. 1998;70:119–23.PubMedCrossRef
Rance NE. Menopause and the human hypothalamus: evidence for the role of kisspeptin/neurokinin B neurons in the regulation of estrogen negative feedback. Peptides. 2009;30:111–22.PubMedCrossRef